Emerging liquid biopsy tools to analyse cancer biomarkers: electrochemical sensors and extracellular vesicle analysis
Biochemical Society Transactions · 2026
DOI: 10.1042/bst20253109 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Society Transactions, 2026. Verfasst von Anitha Devadoss und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biological Chemistry, Biophysics and Bioengineering, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh EH14…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Extracellular Vesicles, Electrochemical Techniques, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Better biomarker analysis technologies can provide improvements in the detection, characterisation and monitoring of cancer and less invasive sampling of blood and other body fluids can improve acceptability and affordability. Here, we discuss these technologies with a specific focus on recent advances in electrochemical sensors, specifically for the analysis of extracellular vesicles (EVs). Widely used biomarker tests with relatively high sensitivity (e.g. ELISAs) are limited by their cost, storage requirements and shelf-life, and ease of use away from centralised facilities. Moreover, their limits of detection (most commonly in the nanomolar to picomolar, with new technologies pushing into the femtomolar range) remain challenged by low abundance biomarkers. Here, we discuss how electrochemical sensor platforms, although often requiring more effort to adapt for new analytes, can provide high sensitivity and direct quantitation at low cost. These platforms are also often simpler to use away from testing facilities. Additionally, we explore how EVs, by protecting nucleic acid and protein cargos from degradation, may facilitate the collective enrichment from blood samples of multiple tumour-derived biomarkers. Continued progress in analysis technologies, alongside a deeper understanding of biomarker biology and clinical value, holds the potential to improve outcomes for the increasing numbers of individuals diagnosed with cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biological Chemistry, Biophysics and Bioengineering, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, U.K.
- Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XR, U.K.
ORCID-Profile: Anitha Devadoss, Michael R Furness, Nathan J W Wu, Nick R Leslie
Zitieren
APA
Devadoss, A., Furness, M. R., Wu, N. J. W., Oikonomidou, O., Kersaudy-Kerhoas, M., & Leslie, N. R. (2026). Emerging liquid biopsy tools to analyse cancer biomarkers: electrochemical sensors and extracellular vesicle analysis. Biochemical Society Transactions. https://doi.org/10.1042/bst20253109
Vancouver
Devadoss A, Furness MR, Wu NJW, Oikonomidou O, Kersaudy-Kerhoas M, Leslie NR. Emerging liquid biopsy tools to analyse cancer biomarkers: electrochemical sensors and extracellular vesicle analysis. Biochemical Society Transactions. 2026. doi:10.1042/bst20253109
BibTeX
@article{Devadoss2026,
author = {Devadoss, Anitha and Furness, Michael R and Wu, Nathan J W and Oikonomidou, Olga and Kersaudy-Kerhoas, Maïwenn and Leslie, Nick R},
title = {Emerging liquid biopsy tools to analyse cancer biomarkers: electrochemical sensors and extracellular vesicle analysis},
journal = {Biochemical Society Transactions},
year = {2026},
doi = {10.1042/bst20253109}
}
EUVIMED